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Abstract
Background: Cardiovascular disease is a leading cause of morbidity and mortality worldwide and epidemiological 
studies have consistently shown an increased risk for cardiovascular events in relation to exposure to air pollution. The 
Israel Study of First Acute Myocardial Infarction was designed to longitudinally assess clinical outcomes, psychosocial 
adjustment and quality of life in patients hospitalized with myocardial infarction. The current study, by introducing 
retrospective air pollution data, will examine the association between exposure to air pollution and outcome in 
myocardial infarction survivors. This report will describe the methods implemented and measures employed. The 
study specifically aims to examine the relationship between residential exposure to air pollution and long-term risk of 
recurrent coronary event, heart failure, stroke, cardiac and all-cause death in a geographically defined cohort of 
patients with myocardial infarction.
Methods/Design: All 1521 patients aged ≤65 years, admitted with first myocardial infarction between February 1992 
and February 1993 to the 8 hospitals serving the population of central Israel, were followed for a median of 13 years. 
Data were collected on sociodemographic, clinical and environmental factors. Data from air quality monitoring stations 
will be incorporated retrospectively. Daily measures of air pollution will be summarised, allowing detailed maps to be 
developed in order to reflect chronic exposure for each participant.
Discussion: This study addresses some of the gaps in understanding of the prognostic importance of air pollution 
exposure after myocardial infarction, by allowing a sufficient follow-up period, using a well-defined community cohort, 
adequately controlling for multiple and multilevel confounding factors and providing extensive data on various 
outcomes.
Background
Cardiovascular disease (CVD) is a leading cause of mor-
bidity and mortality in Israel and worldwide. The esti-
mated incidence of myocardial infarction (MI) in Israel
ranges between 20,000 and 30,000 annually [1]. Despite
remarkable achievements in acute cardiac care and sec-
ondary prevention, MI patients remain a high-risk group
[2]. Considering Israel's ageing population [3] and the
improved survival of cardiac patients [1,2,4], an increase
in CVD burden is anticipated in the following years.
Over the past two decades, epidemiological studies
conducted worldwide have consistently shown an
increased risk for CVD events in relation to short- and
long-term exposure to air pollution [5]. Several large
cohort studies have demonstrated an independent associ-
ation between exposure to air pollution and cardiovascu-
lar mortality [6,7]. In a time series analysis of emergency
admissions to London hospitals, Poloniecki et al. showed
that MI was positively associated with black smoke, nitro-
gen dioxide (NO2), carbon monoxide (CO) and sulphur
dioxide (SO2) and estimated that 1 in 50 cases were trig-
gered by outdoor air pollution [8]. Furthermore, a reduc-
tion in air pollution has been associated with a significant
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Page 2 of 7decrease in cardiovascular deaths [9]. Exposure to traffic-
related air pollution has recently been associated with
daily mortality in five European cities, with a stronger
effect observed in MI survivors than in the general popu-
lation [10]. Among those who survived an MI, chronic
exposure to particulate pollution was associated with
adverse outcomes [11]. The elderly, lower socioeconomic
status (SES) populations and patients with underlying
cardiopulmonary disease or diabetes have been found to
be particularly prone to air pollution effects [5,12].
Studies of adverse health effects related to air pollution
have measured a range of compounds, including nitrates,
sulphates, ozone, CO and particulate matter (PM), with
fine PM, less than 2.5 μm in diameter, presenting the
greatest risk to health [6,13,14]. Pope et al. [15] reported
that "fine particulate air pollution is a risk factor for CVD
mortality," and demonstrated that a 10-μg/m3 elevation in
fine PM was associated with an 8% to 18% increase in
mortality risk for ischemic heart disease, dysrhythmias,
and heart failure.
Although the mechanisms behind this association are
not yet fully known, both animal and human studies sug-
gest that chronic air pollution exposure may accelerate
atherosclerosis [16,17]. Indeed, a population-based study
demonstrated that coronary atherosclerosis was higher
for participants living near a major road [18]. Air pollu-
tion from diesel exhaust has also been associated with
increased thrombus formation [19].
However, methodological limitations inherent in most
previous follow-up studies of MI patients challenge their
applicability. The current study addresses many of these
methodological problems, by defining MI with standard-
ized clinical criteria rather than administrative data; by
providing extensive information on important potential
confounders (e.g., smoking, disease severity indices and
SES measures); by ensuring sufficient follow-up; and by
assessing multiple clinical outcomes longitudinally.
Methods and Design
Objective
This study will investigate the relationship between resi-
dential exposure to air pollution and long-term health
outcomes in a geographically defined cohort of patients
with first acute MI.
Specific aims
This study aims to evaluate the associations of cumulative
exposure to air pollutants (NOx, SO2, and PMx) with the
occurrence of clinical outcomes after MI, namely: recur-
rent coronary event; heart failure; stroke; cardiac death;
and all-cause death, during a median follow-up of
approximately 13 years (Figure 1). The study will assess
the incremental value of air pollution exposure over (a)
individual-level demographic, socioeconomic and clinical
variables; and (b) neighbourhood-level SES, in predicting
long-term morbidity and mortality post-MI. The effect
modification of the above relationships by factors such as
smoking, gender, SES, and comorbidity will be examined.
Hypothesis
Chronic exposure to air pollutants is independently asso-
ciated with long-term adverse outcomes post-MI. Het-
erogeneity in the magnitude of the association exists
between different subsets of patients.
Design
The current study is a historical prospective cohort study
with a median of 13 years follow-up from time of incident
MI. Data will be drawn from the Israel Study of First
Acute Myocardial Infarction, a longitudinal prospective
multicentre investigation of the role of sociodemo-
graphic, medical, environmental and psychosocial vari-
ables in long-term clinical outcomes, psychosocial
adjustment and quality of life in patients hospitalized
with incident acute MI over a 1-year period [20]. This
study provides a wealth of data on post-MI outcomes
with a relatively large sample and a high response rate,
representing 98% of all non-fatal first MI cases in central
Israel within the study period. Data on air pollution will
be retrospectively incorporated into the already complete
follow-up investigation of the parent study population.
Study population
A geographically defined population was used. A total of
1626 patients aged ≤65 years were admitted to the 8 med-
ical centres in central Israel with incident acute MI
between February 15, 1992 and February 15, 1993. Of
these, 81 (5%) died during initial hospitalization, leaving
1545 eligible candidates for the study, of which 1521
(98%) agreed to participate and completed follow-up.
MI definition
Initial MI was defined by clinical criteria and verified by a
senior cardiologist, as the presence of at least two of the
following: (a) chest pain lasting at least 20 minutes;
(b) ECG changes compatible with Q wave or non Q
wave MI; and (c) creatine kinase elevation ≥1.5 times the
upper limit of normal or creatine kinase MB fraction >5%
when simultaneous reference creatine kinase levels
exceeded the upper limit of normal.
Data collection
The entire inpatient and outpatient medical record and
data obtained through structured interviews were used to
ascertain demographics, SES measures, CVD risk factors,
MI characteristics and severity indices, and acute man-
agement and treatment variables. Initial interviews were
conducted approximately 1 week after the index hospital-
ization (T1). Four follow-up interviews were subse-
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years (T4) and 10-13 years (T5) after MI.
Socioeconomic status characteristics
Individual SES data were self-reported at baseline and
included the following measures: area of origin, family
income relative to the national average (categorized as
below average, average or above average), education
(years of schooling), living with a steady partner, and pre-
MI employment status (full-time, part-time or none;
manual vs. non-manual). Income and employment status
were also reported in follow-up interviews. Neighbour-
hood-level SES was estimated through an index devel-
oped by the Israel Central Bureau of Statistics [21], which
summarizes socioeconomic measures from the 1995
National Census data, allowing the classification of small
geographical units into SES categories (using a 20-point
scale). Geographic Information System (GIS) tools were
used to assign patients' addresses to the appropriate SES
categories. Further information on neighbourhood SES
[22] and individual income, employment and education
[20,23] is published elsewhere.
Clinical variables
All medical data were reviewed, abstracted, and verified
by a senior cardiologist (Y.D.). Smoking habits including
intensity (number of cigarettes smoked per day), duration
(years of smoking) and time since cessation were
reported at T1, with the former reassessed at all follow-
up interviews (T2-T5). Detailed data on smoking are
published elsewhere [24]. Height and weight were
recorded at T1 and again during follow-up. Obesity was
defined as body mass index ≥30 kg/m2. Hypertension (T1
and T5) was defined as systolic blood pressure ≥140 mm
Hg, diastolic blood pressure ≥90 mm Hg, or antihyper-
tensive medication use. Diabetes mellitus (T1 and T5)
was defined as (a) fasting blood glucose ≥126 mg/dl on
repeated measurements; (b) 2-hour blood glucose ≥200
mg/dl following glucose loading; or (c) insulin or oral
hypoglycaemic medication use and a history consistent
with diabetes. Dyslipidemia (T1 and T5) was defined
based on the following criteria: (a) elevated total choles-
terol (>200 mg/dl); (b) elevated LDL cholesterol (>100
mg/dl); (c) low HDL cholesterol (<40 mg/dl for men, <50
mg/dl for women); or (d) elevated triglycerides (>150 mg/
dl), in the context of a physician's diagnosis of dyslipi-
demia. Leisure time physical activity (regular, irregular or
none) in the year preceding the index MI was self-
reported at T1 and reassessed during follow-up (T2-T5).
Comorbidity (T1) was assessed using the Charlson index
[25]. MI characteristics and severity indicators included
infarct type and location (T1), Killip class (T1) and left
ventricular ejection fraction (T1 and T5). Revasculariza-
tion procedures performed during follow-up included
percutaneous coronary intervention and coronary artery
bypass grafting. Medication use (e.g., aspirin, beta-block-
ers and statins) was recorded at baseline and during fol-
low-up (T5). Baseline and subsequent reports of self-
rated health, a 5-point scale measure (5 = excellent
health), were recorded as a measure of subjective health
[26].
Air pollution measures
Air pollution data for the study period will be retrospec-
tively sourced from 24 air quality monitoring (AQM) sta-
Figure 1 Summary of the Design Scheme
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Page 4 of 7tions distributed throughout central Israel. Estimates of
exposure to different air pollutants will be calculated for
each patient based on geo-coded residential location and
proximity to a major roadway, taking into account tempo-
ral changes and changes in residential location.
Concentrations of three pollutants will be analyzed.
Sulphur dioxide is emitted to the atmosphere mainly
from industrial sources, in particular power plants.
Nitrogen oxides are a product of combustion processes
and in the study region are mostly associated with traffic-
related emissions [27]. The concentrations of these two
pollutants are not expected to be correlated, thereby pro-
viding independent measures of air pollution exposure
[28]. Particulate matter, produced mainly by traffic and
heavy industry, will also be analyzed, with emphasis on
two fractions: PM10 (particulate matter with diameter
smaller than 10 μm) and PM2.5 (fine particulate matter
with diameter smaller than 2.5 μm).
Concentration maps for each pollutant will be created
using the kriging algorithm over the greater Tel Aviv area
for different averaging periods. The reliability of the maps
will be assessed by a complete cross validation procedure,
in which each station, in turn, will be omitted from the
dataset and its records estimated by extrapolation of data
from the other stations. The difference between the true
and estimated results over the whole study period at each
of the stations will serve as a credibility measure [29].
These average air pollution measures will be used to cre-
ate an individual risk metric of exposure to pollutants for
each participant.
In addition to data from the AQM stations, traffic
counts will be used in circular "buffer zones" of 100 m
radius around each of the reporting monitoring stations.
These vehicle-specific type counts may be used within a
co-kriging procedure, thus modifying the concentration
maps to take account of the effect of local traffic volume
on air quality.
Exposure assessment determines the extent of exposure
to a hazardous agent and refers both to measurements as
well as to model predictions of the fate of chemicals in the
environment. Primary exposure metrics will be based on
long-term average concentrations of different air pollut-
ants. Additionally, different features of the concentration
distributions (mode, median, upper percentiles, standard
deviation) will be used as risk metrics, representing
extreme exposures as well as the variation of exposures.
Improved risk estimation will be obtained by using
additional metadata, such as the frequency with which
pollutant concentrations exceeded the Israeli National
Ambient Air Quality Standards (NAAQS) [30] in the
nearby monitoring station during the period studied, and
the distance of the patient's residence from a major road-
way (following the Ministry of Transportation's road cod-
ing).
Outcome measures
Outcomes will include time to the following endpoints:
(a) recurrent coronary event; (b) heart failure; (c) stroke;
(d) cardiac death; and (e) all-cause death. Follow-up was
initiated at the index MI (1992-3) and lasted through
December 31, 2005 (loss to follow-up <2%). Recurrent
coronary event will be composed of recurrent MI, unsta-
ble angina pectoris or cardiac death. All clinical outcomes
were ascertained through various sources of data, includ-
ing medical records, the Israeli Population Registry, death
certificates, hospital charts, family physicians and family
members and verified by a trained physician.
Ethics
All aspects of the study have been approved by the appro-
priate Institutional Ethics Committees. The parent study
has been approved by the Ethics Committees of all medi-
cal centres involved (Wolfson, Holon; Sheba, Tel
Hashomer; Tel Aviv Sourasky, Tel Aviv; Meir, Kfar Sava;
Assaf Harofeh, Zerifin; Beilinson, Petach Tikvah; Hasha-
ron, Petach Tikvah; and Laniado, Netanya) and ratified by
the Institutional Ethics Committee of Tel Aviv University
both before T1 and T5. All participants gave written
informed consent at both time periods. The current
study, which does not involve any additional patient con-
tact, has been approved by the Institutional Ethics Com-
mittee of Tel Aviv University.
Sample size and power calculation
With a sample size of over 1,500 participants followed up
for a median of 13 years (interquartile range 12-14 years),
the average probabilities of surviving (or not experiencing
the specific endpoint) to end of follow-up are as follows:
27% for recurrent coronary event; 75% for heart failure;
83% for stroke; 79% for cardiac mortality; and 72% for all-
cause mortality. Table 1 summarizes the estimated statis-
tical power for detecting a minimum hazard ratio (HR)
for various outcomes in the upper quartile vs. lower
quartiles of air pollution exposure, given a significance
level of 5%. Comparable effect sizes (HRs ≈ 1.4) were
reported in previous studies [7,11].
Statistical analyses
Survival across air pollution exposure categories, esti-
mated using the Kaplan-Meier method with right censor-
ing at the time of last follow-up, will be compared by the
log-rank test. Cox proportional hazards regression mod-
els will be constructed to evaluate the HRs for clinical
outcomes associated with exposure groups (e.g. quartiles
of air pollution levels) handled as time-dependent covari-
ates. These regressions model the effects of subjects
transferring from one exposure group to another during
follow-up. In order to handle informative censoring in
survival analyses of outcomes other than death (e.g.
recurrent coronary event), proportional sub-distribution
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ing for death as a competing risk [31,32]. The proportion-
ality assumption will be tested with the Schoenfeld
residuals. Sequential adjustment will be made for demo-
graphic, socioeconomic and clinical variables. Since
accumulating evidence suggests that an individual's
health is influenced by the socioeconomic characteristics
of his or her residential area, above and beyond personal
SES [22,33], further adjustment for neighbourhood-level
SES will be made. Hence, residual confounding of the
association between air pollution and post-MI outcomes
by area-level SES will be minimized. Effect modification
of the above relationships by smoking, gender, SES, and
diabetes will be assessed by including 2-way interaction
terms (e.g. smoking-by-air pollution) in the models.
Within a given air pollution-defined area, patients may be
more alike with respect to unmeasured characteristics
than they are between areas, therefore mixed-effects
regression models will be examined, accounting for intra-
area correlation [22,33,34].
As all outcome events, except for death, may have
occurred more than once over the follow-up time for a
given subject, ancillary analyses will be performed apply-
ing recurrent event survival analysis, with robust variance
estimators computed to address the likely correlation
between recurrent events in the same patient. Analyses
will be performed using SAS version 9.1 (SAS Institute
Inc, Cary, NC), R version 2.9 (R Development Core Team
[35]), and SPSS version 18 (SPSS Inc., Chicago, IL).
Initial Results
Participants had a mean (SD) age of 54(8) years at study
entry, 19% were female, 24% were unemployed prior to
MI, 47% reported a below average income and 50% had
less than 12 years of education. CVD risk factors were
highly prevalent at baseline, including smoking (50%),
hypertension (38%) and physical inactivity (72%).
Clinical outcomes occurring during the follow-up are
summarized in Table 2. Among 1521 patients, 427 deaths
occurred, of which 70% were cardiac deaths.
Discussion
Study strengths
Critics of previous studies have suggested that poorly
measured confounding factors, particularly SES indica-
tors, may account at least partly for the association
between air pollution and death rates [5]. Furthermore,
previous research suggests an additional contribution of
residential neighbourhood to post-MI mortality risk,
beyond individual SES [22]. The current study provides
multiple socioeconomic measures, both individual SES
and neighbourhood SES based on national census data,
reflecting the multidimensional nature of this construct.
Participants were included in the current study based on
clinical definition of MI as ascertained by a senior cardi-
ologist (Y.D.), as opposed to administrative or registry-
based definitions criticized in previous studies.
The ethnic, cultural and socioeconomic diversity of the
study population is an advantage, and the inclusion of
98% of patients aged 65 or less who survived first MI in
the specified geographical area makes the results highly
generalizable. The extended follow-up of 13 years pro-
vides a wealth of data, allowing a comprehensive exami-
nation of the relationship between air pollution exposure
and long-term clinical outcomes in MI survivors over a
period of time.
Methodological considerations
The study is limited by the availability of air monitoring
data. The air pollution index is therefore an estimate
based on available data. However, maps depicting the
annual average concentrations of all measured pollutants
will be produced and provided that the pollutant-specific
spatial patterns are consistent over time, the assessment
of high-risk areas will be possible even in years with
sparse data. Since some areas lack a monitoring station,
data will be extrapolated from the available stations.
The heterogeneity in exposure to air pollution in the
study area may be limited, since all participants resided in
central Israel which, as well as covering over a third of the
Table 1: Power Calculation for Detecting Associations Between Air Pollution Categories (Q4 vs. Q1-3) and Primary Outcomes
Least Extreme Detectable Hazard Ratio
Power Recurrent Coronary Event Heart Failure Stroke Cardiac Mortality All-Cause Mortality
80% 1.21 1.37 1.47 1.40 1.35
85% 1.23 1.40 1.50 1.43 1.37
90% 1.25 1.43 1.55 1.47 1.40
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Page 6 of 7population, is impacted by heavy traffic and is mostly
devoid of heavy industry.
Finally, the study population is a relatively "old" MI
cohort, with incident MI occurring between 1992-1993.
Definition of MI has since changed to include measure-
ment of more recent cardiac biomarkers (troponins),
found to be more sensitive than creatine kinase.
Expected outcomes and contribution
As recently documented in a scientific statement from
the American Heart Association concerning air pollution
and CVD: "epidemiological investigations designed to
address some of the limitations of prior reports are
required", and include, among others: a better character-
ization of high-risk populations; investigation of the role
of confounders; assessment of the effect of medications
on the air pollution-CVD risk association; and a more
thorough examination of the relationships between ambi-
ent air pollution concentrations and various adverse car-
diovascular outcomes [5]. The current study presents a
unique opportunity to respond to all of these recognized
needs and benefits from extensive data on sociodemo-
graphics, risk factors and post-MI prognostic determi-
nants, as well as multiple outcome measures. Limitations
of previous research will be addressed by concurrently
controlling for multiple and multilevel SES indicators, in
addition to other important confounders such as various
smoking-related parameters, disease severity indices and
treatment.
This study will investigate the association between
cumulative exposure to air pollution and clinical out-
comes post MI and has implications for informing policy
on air pollution. As recently acknowledged by experts in
environmental epidemiology, "assessment of the effects of
air pollution on potentially susceptible subpopulations is
key to providing policy-relevant information to better
protect the vulnerable" [36]. The current study addresses
this issue by focusing on the hazardous effects of air pol-
lution in a relatively large group of patients who have
been suggested to be particularly susceptible to this kind
of exposure.
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